Back to VRTX
MACKENZIE FINANCIAL CORP → VRTX
MACKENZIE FINANCIAL CORP VRTX Position History
Vertex Pharmaceuticals Incorporated • Healthcare
Quarters held
5
Latest value
$78.6M
Q3 2026
Peak value
$78.6M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $21.3M |
| Q4 2025 | $28.7M |
| Q1 2026 | $43.2M |
| Q2 2026 | $51.1M |
| Q3 2026 | $78.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $78.6M | 150.4K | — | — |
| Q2 2026 | $51.1M | 102.9K | — | — |
| Q1 2026 | $43.2M | 96.7K | — | — |
| Q4 2025 | $28.7M | 63.3K | — | — |
| Q3 2025 | $21.3M | 54.3K | — | — |
Other funds holding VRTX
$10.8B
$10.1B
$9.8B
$8.5B
$5.9B
$5.9B
$5.7B
$5.5B